A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
Unequal access to the COVID-19 vaccine fuelled calls for a patent waiver, but any major change needs to ensure a better outcome for developing economies.
How do we enable people to make evidence-based, health and life-protecting choices in a pandemic?
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
We need to fix our COVID-19 and vaccine rollout interpreting services – and translated information – so vulnerable pockets of our diverse population aren’t forgotten.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
The successful uptake of Australia’s COVID program hinges on tailored communication campaigns that appeal to all sectors of the community.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
We'll struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
When Monash University announced world-first COVID-19 research in July, the crucial behind-the-scenes work of a group of PhD students went largely unnoticed.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Forget the finger-pointing – public communications that promote collective action will make our pandemic-clouded lives a little easier.
Deliberately infecting people with a disease-causing agent as part of medical research can be ethically acceptable, and even necessary.
Dummy text